Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Aveiro – page 2

46 clinical trials in Aveiro, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Aveiro at a glance
46
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

46 trials in Aveiro

Open in trial search

IgA nephropathy

Recruiting

Study of felzartamab compared to placebo in adults with IgA nephropathy

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Codeine Phosphate
  • Sponsor:Biogen Idec Research Limited

Myelofibrosis

Recruiting

Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Navtemadlin
  • Sponsor:Kartos Therapeutics Inc.
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Mavorixafor
  • Sponsor:X4 Pharmaceuticals Inc.

Study on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Aficamten
  • Sponsor:Cytokinetics Inc.

Study on TAK-330 for Reversing Anticoagulation in Patients on Factor Xa Inhibitors Needing Urgent Surgery

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Protein C
  • Sponsor:Takeda Development Center Americas Inc.

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Urinary tract infection

Not yet recruiting

MV140 for Women with Recurrent Uncomplicated Urinary Tract Infections

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Inmunotek S.L.

A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Zampilimab
  • Sponsor:Chiesi Farmaceutici S.p.A.

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Study on the Effectiveness and Safety of Brensocatib for Patients with Chronic Rhinosinusitis Without Nasal Polyps

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Brensocatib
  • Sponsor:Insmed Inc.

Obesity

Not recruiting

Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Aveiro

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on cardiovascular conditions, including studies of new treatments for acute myocardial infarction and hypertrophic cardiomyopathy. Researchers are evaluating novel therapies for stroke prevention and heart-related complications.

  • Hypertrophic Cardiomyopathy Treatment
  • Stroke Prevention Therapies
  • Acute Myocardial Infarction Management

Advanced studies targeting improved outcomes in patients with various cardiac conditions through innovative therapeutic approaches.

02 Respiratory Medicine

Research initiatives addressing chronic respiratory conditions, with particular emphasis on chronic rhinosinusitis and COPD. Studies are evaluating new therapeutic agents for managing symptoms and improving patient quality of life.

  • Chronic Rhinosinusitis Treatment
  • COPD Management
  • Nasal Polyps Therapy

Comprehensive trials exploring both symptomatic relief and long-term disease modification strategies.

03 Metabolic Disorders

Clinical investigations into metabolic conditions, focusing on obesity, diabetes, and related complications. Studies are examining new treatments for hypertriglyceridemia and innovative approaches to weight management.

  • Obesity Treatment
  • Diabetic Complications
  • Lipid Management

Groundbreaking research aimed at developing effective therapies for metabolic disorders and their associated complications.

04 Hematology Research

Studies investigating treatments for blood disorders, particularly focusing on conditions like Paroxysmal Nocturnal Hemoglobinuria and various forms of neutropenia. Researchers are evaluating novel therapeutic approaches.

  • PNH Treatment Development
  • Neutropenia Management
  • Blood Disorder Therapies

Innovative clinical trials exploring new treatment options for rare and chronic blood conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.